The Texas Biomedical Research Institute is:

  • One of the world's leading nonprofit independent biomedical research institutions

    Since its founding in 1941 by Thomas B. Slick Jr., the Texas Biomedical Research Institute has gained worldwide recognition in scientific and academic communities for the quality of its basic research. Each year, our scientists publish well over 100 articles in the international scientific literature. Their discoveries contribute important new information that helps advance the scientific community's effort to improve health and save lives.
  • Advancing our knowledge of human diseases

    Our scientists conduct biomedical research to improve human health. They are detecting diseases and finding out what causes them. They are discovering new methods for disease prevention. Our scientists are working to find cures, and ultimately, to eradicate disease.
  • Research that benefits human health

    The major research programs include studying cardiovascular disease and its associated risk factors; cancer; infectious diseases such as AIDS, hepatitis and herpes; new and emerging disease threats and possible bioterror agents such as anthrax and Ebola; the role of genetics in human diseases such as heart disease, diabetes, osteoporosis, arthritis, epilepsy, mental illness, and the pregnancy disorder preeclampsia; Parkinson's disease, multiple sclerosis, ALS (Lou Gehrig's Disease); fetal growth and development; hormonal research; and diseases of the eye.
  • Where the buck starts in biomedical research

    Before a new drug, vaccine or other medical breakthrough can come about, researchers must first make advances in basic research areas. Texas Biomed is where this research begins.
  • Member of the Southwest Research Consortium

    in partnership with the University of Texas Health Science Center at San Antonio, the Southwest Research Institute, the University of Texas at San Antonio, and Trinity University, San Antonio.
  • Member of the Association of Independent Research Institutes (AIRI)

    a nationwide association of independent, not-for-profit research institutes conducting peer-reviewed basic and applied research in the biomedical and behavioral sciences.
  • Member of the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases, established by the National Institutes of Health in 2003

    The primary research focus of the eight new RCEs is on agents the government has determined to be bioterror threats, often described as “select agents.” Examples include anthrax, bubonic plague, Ebola, tularensis, and viral hemorrhagic fevers. The program, however, also addresses emerging infectious diseases such as dengue fever, monkeypox and SARS. Texas Biomed is part of the RCE for Region VI, which is headed by the University of Texas Medical Branch at Galveston.

More Facts